Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The temperature-controlled packaging solutions for the pharmaceuticals market is expected to record an above-average growth rate during the forecast period. The key end use industries for the temperature-controlled packaging solutions for pharmaceuticals are healthcare, biomedical, and chemical industries.
Given the increase in demand for a conducive environment for pharmaceuticals, efforts have been made by manufacturers to work on the quality of the perishable pharma products.
In addition, the intervention of the central healthcare bodies is also a key influencer driving the growth of the temperature-controlled packaging solutions for the pharmaceuticals market.
For instance, the Food and Drug Administration (FDA) in the U.S. has defined a regulation under distribution procedures, which states that pharmaceuticals are to be shipped with the right temperatures.
As a result, companies operating in the temperature-controlled packaging solutions for the pharmaceuticals market are looking at electronic temperature and humidity equipment for the proper delivery and dispatch of the delivery drugs.
During the spread of the pandemic, the temperature-controlled packaging solutions for the pharmaceuticals market witnessed a significant boost, as dependency on healthcare and pharmaceutical was high among individuals. Besides this, multiple uses of temperature-controlled packaging solutions for vaccines and other medicines to cure and prevent coronavirus are expected to amplify the market growth during the forecast period.
On the flip side, there have been several deterrents that are impacting the moderate growth of the temperature-controlled packaging solutions for the pharmaceuticals market. Among the others, low awareness regarding the availability of technology to maintain the right temperature for pharmaceutical packaging in some parts of the developing countries is impacting the true market potential.
In addition, the cost of advanced temperature-controlled packaging is a key concern for numerous pharmaceutical companies. This could hamper the growth pace of the temperature-controlled packaging solutions for the pharmaceuticals market during the forecast period.
Strong Emphasis on Waste Reduction of Critical Biologics to Boost Demand
The global demand for temperature-sensitive vaccines is anticipated to grow 6-7% annually. International organizations, such as World Health Organization (WHO), are continuously focusing on reducing wastage of vaccines across the globe.
For instance, in 2012, World Health Organization estimated global liquid vaccine wastage at a staggering 25%, primarily attributed to disruptions in cold chain supply.
As a part of this, various programs have been initiated to monitor vaccine wastage. These programs also focus on proper handling and transportation of vaccines and in turn, are driving the demand for temperature controlled packaging.
Principal Consultant
The need for better handling of temperature-sensitive pharmaceutical products has resulted in increased research for more advanced temperature controlled packaging insulation materials such as VIP, PCMs, and sheep wool.
VIP-based insulation and PCM-based refrigerants offer major advantages over conventional expanded polystyrene (EPS) and polyurethane insulated shippers. Shippers implementing VIPs and PCMs are relatively lightweight, provide wide temperature ranges, cut distribution costs, and thus, are gaining market share.
Cold chain packaging, particularly for pharmaceuticals is exposed to rigorous climatic conditions, wherein the packaged pharmaceutical products are shipped through different modes of transportation, including ocean transportation. This increases the risk of direct exposure of the packaged product to sunlight, dwell time on the dock, and stress on the package due to other products in the container.
As only a handful of manufacturers test their pharmaceutical packaging products to bear such stress, not all suppliers can meet client requirements. Therefore, a large portion of the industry is facing issues related to temperature controlled pharmaceutical packaging product performance across different climatic conditions and thus, do not meet quality standards.
Furthermore, exhibiting minimal or no external environment impact on the stored product is also important for pharmaceutical companies, as there are reported incidences wherein variation in the pharmaceutical product’s storage temperature resulted into a profound impact on drug’s stability and therapeutic efficacy.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Forecast Period | 2015 to 2019 |
| Historical Data Available for | 2020 to 2030 |
| Market Analysis | US$ Million for Value and Units for Volume |
| Key Regions Covered | North America; Latin America; Western Europe; Eastern Europe; Asia Pacific Excluding Japan; Japan and Middle East & Africa (MEA) |
| Key Countries Covered | USA, Canada, Germany, Brazil, Mexico, Rest of Latin America, UK, France, Italy, Spain, Rest of Europe, Nordic, BENELUX, Rest of Western Europe, Russia, Poland, Rest of Eastern Europe, ASEAN, Japan, India, China, South Korea, Rest of Asia Pacific excluding Japan, Australia, New Zealand, GCC, North Africa, South Africa, Rest of MEA |
| Key Segments Covered | Product, Application, Region |
| Key Companies Profiled | Sonoco Products Company; Pelican Biothermal; Sofrigam SA Ltd.; Cryopak; Cold Chain Technologies; Envirotainer Ltd.; va-Q-tec AG; Inmark Packaging; American Aerogel Corporation |
| Report Coverage | Market Overview, Key Market Trends, Key Success Factors, Demand Analysis, Market Background, COVID-19 Analysis, Segmental Analysis, Regional Profiling, Market Structure & Competition Analysis |
| Customization & Pricing | Available Upon Request |
On the basis of product type :
On the basis of application :
The temperature-controlled packaging solutions for pharmaceuticals market is likely to secure a CAGR of 7.8% through 2032.
The temperature-controlled packaging solutions for pharmaceuticals market size is estimated to cross US$ 10.02 Bn by 2032.
The temperature-controlled packaging solutions for pharmaceuticals market is likely to record a value of US$ 4.73 Bn in 2022.
North America is likely to lead the temperature-controlled packaging solutions for pharmaceuticals market.
1. Executive Summary 1.1. Market Overview 1.2. Market Analysis 1.3. FMI Analysis and Recommendations 1.4. Wheel of Opportunity 2. Market Introduction 2.1. Market Definition 2.2. Market Taxonomy 3. Market Background 3.1. Porter’s Analysis 3.2. Macro-Economic Factors 3.3. Forecast Factors – Relevance & Impact 3.4. Value Chain Analysis & Profitability Margin 3.5. Market Dynamics 3.5.1. Drivers 3.5.2. Restraints 3.5.3. Trends 3.6. Opportunity Analysis 4. Market Forecast 4.1. Market Volume Projections 4.2. Pricing Analysis 4.3. Market Size Projections 4.4. Y-o-Y Projections 4.5. Absolute $ Opportunity Analysis 5. Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis By Product Type 5.1. Introduction 5.1.1. Market Value Share Analysis By Product Type 5.1.2. Y-o-Y Growth Analysis By Product Type 5.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type 5.2.1. Insulated Shippers 5.2.1.1. Panels and Envelopes 5.2.1.2. EPS Foam Container 5.2.1.3. Fiberboard 5.2.1.4. PUR 5.2.2. Insulated Protective Shippers 5.2.3. Insulated Containers 5.2.3.1. Chest Style 5.2.3.2. Upright Style 5.2.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 5.3. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type 5.3.1. Insulated Shippers 5.3.1.1. Panels and Envelopes 5.3.1.2. EPS Foam Container 5.3.1.3. Fiberboard 5.3.1.4. PUR 5.3.2. Insulated Protective Shippers 5.3.3. Insulated Containers 5.3.3.1. Chest Style 5.3.3.2. Upright Style 5.3.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 5.4. Market Attractiveness Analysis By Product Type 6. Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis By Application 6.1. Introduction 6.1.1. Market Value Share Analysis By Application 6.1.2. Y-o-Y Growth Analysis By Application 6.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application 6.2.1. Frozen 6.2.2. Chilled 6.2.3. Ambient 6.3. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application 6.3.1. Frozen 6.3.2. Chilled 6.3.3. Ambient 6.4. Market Attractiveness Analysis By Application 7. Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis By Region 7.1. Introduction 7.1.1. Market Value Share Analysis By Region 7.1.2. Y-o-Y Growth Analysis By Region 7.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Region 7.2.1. North America 7.2.2. Latin America 7.2.3. Western Europe 7.2.4. Eastern Europe 7.2.5. Asia Pacific 7.2.6. MEA 7.2.7. Japan 7.3. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Region 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. Asia Pacific 7.3.6. MEA 7.3.7. Japan 7.4. Market Attractiveness Analysis By Region 8. North America Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis 8.1. Introduction 8.2. Regional Pricing Analysis 8.3. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Country 8.3.1. U.S. 8.3.2. Canada 8.4. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Country 8.4.1. U.S. 8.4.2. Canada 8.5. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type 8.5.1. Insulated Shippers 8.5.1.1. Panels and Envelopes 8.5.1.2. EPS Foam Container 8.5.1.3. Fiberboard 8.5.1.4. PUR 8.5.2. Insulated Protective Shippers 8.5.3. Insulated Containers 8.5.3.1. Chest Style 8.5.3.2. Upright Style 8.5.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 8.6. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type 8.6.1. Insulated Shippers 8.6.1.1. Panels and Envelopes 8.6.1.2. EPS Foam Container 8.6.1.3. Fiberboard 8.6.1.4. PUR 8.6.2. Insulated Protective Shippers 8.6.3. Insulated Containers 8.6.3.1. Chest Style 8.6.3.2. Upright Style 8.6.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 8.7. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application 8.7.1. Frozen 8.7.2. Chilled 8.7.3. Ambient 8.8. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application 8.8.1. Frozen 8.8.2. Chilled 8.8.3. Ambient 8.9. Market Trends 8.10. Key Market Participants – Intensity Mapping 8.11. Drivers and Restraints – Impact Analysis 9. Latin America Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis 9.1. Introduction 9.2. Regional Pricing Analysis 9.3. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Country 9.3.1. Brazil 9.3.2. Mexico 9.3.3. Rest of Latin America 9.4. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Country 9.4.1. Brazil 9.4.2. Mexico 9.4.3. Rest of Latin America 9.5. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type 9.5.1. Insulated Shippers 9.5.1.1. Panels and Envelopes 9.5.1.2. EPS Foam Container 9.5.1.3. Fiberboard 9.5.1.4. PUR 9.5.2. Insulated Protective Shippers 9.5.3. Insulated Containers 9.5.3.1. Chest Style 9.5.3.2. Upright Style 9.5.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 9.6. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type 9.6.1. Insulated Shippers 9.6.1.1. Panels and Envelopes 9.6.1.2. EPS Foam Container 9.6.1.3. Fiberboard 9.6.1.4. PUR 9.6.2. Insulated Protective Shippers 9.6.3. Insulated Containers 9.6.3.1. Chest Style 9.6.3.2. Upright Style 9.6.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 9.7. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application 9.7.1. Frozen 9.7.2. Chilled 9.7.3. Ambient 9.8. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application 9.8.1. Frozen 9.8.2. Chilled 9.8.3. Ambient 9.9. Market Trends 9.10. Key Market Participants – Intensity Mapping 9.11. Drivers and Restraints – Impact Analysis 10. Western Europe Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis 10.1. Introduction 10.2. Regional Pricing Analysis 10.3. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Country 10.3.1. Germany 10.3.2. Italy 10.3.3. France 10.3.4. Spain 10.3.5. U.K. 10.3.6. Nordic 10.3.7. Benelux 10.3.8. Rest of Western Europe 10.4. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Country 10.4.1. Germany 10.4.2. Italy 10.4.3. France 10.4.4. Spain 10.4.5. U.K. 10.4.6. Nordic 10.4.7. Benelux 10.4.8. Rest of Western Europe 10.5. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type 10.5.1. Insulated Shippers 10.5.1.1. Panels and Envelopes 10.5.1.2. EPS Foam Container 10.5.1.3. Fiberboard 10.5.1.4. PUR 10.5.2. Insulated Protective Shippers 10.5.3. Insulated Containers 10.5.3.1. Chest Style 10.5.3.2. Upright Style 10.5.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 10.6. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type 10.6.1. Insulated Shippers 10.6.1.1. Panels and Envelopes 10.6.1.2. EPS Foam Container 10.6.1.3. Fiberboard 10.6.1.4. PUR 10.6.2. Insulated Protective Shippers 10.6.3. Insulated Containers 10.6.3.1. Chest Style 10.6.3.2. Upright Style 10.6.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 10.7. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application 10.7.1. Frozen 10.7.2. Chilled 10.7.3. Ambient 10.8. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application 10.8.1. Frozen 10.8.2. Chilled 10.8.3. Ambient 10.9. Market Trends 10.10. Key Market Participants – Intensity Mapping 10.11. Drivers and Restraints – Impact Analysis 11. Eastern Europe Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis 11.1. Introduction 11.2. Regional Pricing Analysis 11.3. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Country 11.3.1. Russia 11.3.2. Poland 11.3.3. Rest of Eastern Europe 11.4. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Country 11.4.1. Russia 11.4.2. Poland 11.4.3. Rest of Eastern Europe 11.5. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type 11.5.1. Insulated Shippers 11.5.1.1. Panels and Envelopes 11.5.1.2. EPS Foam Container 11.5.1.3. Fiberboard 11.5.1.4. PUR 11.5.2. Insulated Protective Shippers 11.5.3. Insulated Containers 11.5.3.1. Chest Style 11.5.3.2. Upright Style 11.5.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 11.6. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type 11.6.1. Insulated Shippers 11.6.1.1. Panels and Envelopes 11.6.1.2. EPS Foam Container 11.6.1.3. Fiberboard 11.6.1.4. PUR 11.6.2. Insulated Protective Shippers 11.6.3. Insulated Containers 11.6.3.1. Chest Style 11.6.3.2. Upright Style 11.6.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 11.7. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application 11.7.1. Frozen 11.7.2. Chilled 11.7.3. Ambient 11.8. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application 11.8.1. Frozen 11.8.2. Chilled 11.8.3. Ambient 11.9. Market Trends 11.10. Key Market Participants – Intensity Mapping 11.11. Drivers and Restraints – Impact Analysis 12. Middle East and Africa Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis 12.1. Introduction 12.2. Regional Pricing Analysis 12.3. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Country 12.3.1. Northern Africa 12.3.2. GCC Countries 12.3.3. South Africa 12.3.4. Rest of Middle East and Africa 12.4. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Country 12.4.1. Northern Africa 12.4.2. GCC Countries 12.4.3. South Africa 12.4.4. Rest of Middle East and Africa 12.5. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type 12.5.1. Insulated Shippers 12.5.1.1. Panels and Envelopes 12.5.1.2. EPS Foam Container 12.5.1.3. Fiberboard 12.5.1.4. PUR 12.5.2. Insulated Protective Shippers 12.5.3. Insulated Containers 12.5.3.1. Chest Style 12.5.3.2. Upright Style 12.5.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 12.6. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type 12.6.1. Insulated Shippers 12.6.1.1. Panels and Envelopes 12.6.1.2. EPS Foam Container 12.6.1.3. Fiberboard 12.6.1.4. PUR 12.6.2. Insulated Protective Shippers 12.6.3. Insulated Containers 12.6.3.1. Chest Style 12.6.3.2. Upright Style 12.6.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 12.7. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application 12.7.1. Frozen 12.7.2. Chilled 12.7.3. Ambient 12.8. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application 12.8.1. Frozen 12.8.2. Chilled 12.8.3. Ambient 12.9. Market Trends 12.10. Key Market Participants – Intensity Mapping 12.11. Drivers and Restraints – Impact Analysis 13. Asia Pacific Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis 13.1. Introduction 13.2. Regional Pricing Analysis 13.3. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Country 13.3.1. China 13.3.2. India 13.3.3. ASEAN 13.3.4. Australia and New Zealand 13.3.5. Rest of APEJ 13.4. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Country 13.4.1. China 13.4.2. India 13.4.3. ASEAN 13.4.4. Australia and New Zealand 13.4.5. Rest of APEJ 13.5. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type 13.5.1. Insulated Shippers 13.5.1.1. Panels and Envelopes 13.5.1.2. EPS Foam Container 13.5.1.3. Fiberboard 13.5.1.4. PUR 13.5.2. Insulated Protective Shippers 13.5.3. Insulated Containers 13.5.3.1. Chest Style 13.5.3.2. Upright Style 13.5.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 13.6. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type 13.6.1. Insulated Shippers 13.6.1.1. Panels and Envelopes 13.6.1.2. EPS Foam Container 13.6.1.3. Fiberboard 13.6.1.4. PUR 13.6.2. Insulated Protective Shippers 13.6.3. Insulated Containers 13.6.3.1. Chest Style 13.6.3.2. Upright Style 13.6.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 13.7. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application 13.7.1. Frozen 13.7.2. Chilled 13.7.3. Ambient 13.8. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application 13.8.1. Frozen 13.8.2. Chilled 13.8.3. Ambient 13.9. Market Trends 13.10. Key Market Participants – Intensity Mapping 13.11. Drivers and Restraints – Impact Analysis 14. Japan Temperature-controlled Packaging Solutions for Pharmaceuticals Market Analysis 14.1. Introduction 14.2. Regional Pricing Analysis 14.3. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Product Type 14.3.1. Insulated Shippers 14.3.1.1. Panels and Envelopes 14.3.1.2. EPS Foam Container 14.3.1.3. Fiberboard 14.3.1.4. PUR 14.3.2. Insulated Protective Shippers 14.3.3. Insulated Containers 14.3.3.1. Chest Style 14.3.3.2. Upright Style 14.3.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 14.4. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Product Type 14.4.1. Insulated Shippers 14.4.1.1. Panels and Envelopes 14.4.1.2. EPS Foam Container 14.4.1.3. Fiberboard 14.4.1.4. PUR 14.4.2. Insulated Protective Shippers 14.4.3. Insulated Containers 14.4.3.1. Chest Style 14.4.3.2. Upright Style 14.4.4. Other (Refrigerants, gel, icepacks, phase change materials, etc.) 14.5. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis 2013-2017 By Application 14.5.1. Frozen 14.5.2. Chilled 14.5.3. Ambient 14.6. Current Market Size (US$ Mn) and Volume (‘000 Units) Forecast 2018-2028 By Application 14.6.1. Frozen 14.6.2. Chilled 14.6.3. Ambient 14.7. Market Trends 14.8. Key Market Participants – Intensity Mapping 14.9. Drivers and Restraints – Impact Analysis 15. Market Structure Analysis 15.1. Market Analysis by Tier of Companies 15.1.1. By Large, Medium and Small 15.2. Market Concentration 15.2.1. By Top 5 and by Top 10 15.3. Production Material Share Analysis 15.3.1. BY Large, Medium and Small 15.3.2. By Top 5 and Top 10 15.4. Market Share Analysis of Top 10 Players 15.4.1. North America Market Share Analysis by Top Players 15.4.2. Europe Market Share Analysis by Top Players 15.4.3. Asia Pacific Market Share Analysis by Top Players 15.4.4. Latin America Market Share Analysis by Top Players 15.4.5. MEA Market Share Analysis by Top Players 15.5. Market Presence Analysis 15.5.1. By Regional Footprint of Players 15.5.2. Product Footprint by Players 15.5.3. Channel Foot Print by Players 15.6. Technology Roadmap 16. Competition Analysis 16.1. Competition Dashboard 16.2. Pricing Analysis By Competition 16.3. Competition Benchmarking 16.4. Profitability and Gross Margin Analysis By Competition 16.5. Competition Developments 16.6. Competition Deep Dive (20 Companies) 16.6.1. Sonoco Products Company 16.6.1.1. Overview 16.6.1.2. Product Portfolio 16.6.1.3. Profitability 16.6.1.4. Production Footprint 16.6.1.5. Sales Footprint 16.6.1.6. Channel Footprint 16.6.1.7. Competition Benchmarking 16.6.1.8. Strategy 16.6.1.8.1. Marketing Strategy 16.6.1.8.2. Product Strategy 16.6.1.8.3. Channel Strategy 16.6.2. Pelican Biothermal 16.6.3. Sofrigam SA Ltd. 16.6.4. Cryopak 16.6.5. Cold Chain Technologies 16.6.6. Envirotainer Ltd. 16.6.7. va-Q-tec AG 16.6.8. Inmark Packaging 16.6.9. American Aerogel Corporation 16.6.10. Snyder Industries, Inc. 16.6.11. ACH Foam Technologies, LLC 16.6.12. Tempack Packaging Solutions, S.L. 16.6.13. EcoCool GmbH 16.6.14. Exeltainer SL 16.6.15. Intelsius 16.6.16. Inno Cool India Private Limited 16.6.17. Softbox Systems 16.6.18. Insulated Products Corporation 16.6.19. TKT GmbH 16.6.20. Saeplast America Inc. 16.6.21. Emball’ISO
17. Research Methodology
18. Assumptions & Acronyms
Explore Packaging Insights
View Reports
Temperature Controlled Packaging Solutions for Pharmaceuticals Market
